Christophe Weber is president, chief executive officer (CEO) and representative director of Takeda. He joined the company in April 2014 as chief operating officer, was named president …

2 天之前 · CEO Christophe Weber to retire from Takeda in June 2026 after 12 years. Julie Kim, president of the U.S. Business Unit, named to succeed Weber after multi-year succession …

2 天之前 · CEO Christophe Weber to retire from Takeda in June 2026 after 12 years Julie Kim, president of the U.S. Business Unit, named to succeed Weber after multi-year succession …

1 天前 · Takeda announced that its board of directors made the decision unanimously to appoint Julie Kim, currently president of Takeda’s U.S. Business Unit, as the successor to Christophe …

1 天前 · Takeda Pharmaceutical Company Limited / Key word(s): Personnel Takeda Pharmaceutical Company Limited: Julie Kim Will Succeed Christophe Weber as CEO of …

1 天前 · Takeda's long-serving chief executive Christophe Weber has said he will retire next year, after 12 years at the Japanese drugmaker. Weber – who was briefly chief operating officer of …

2 天之前 · CEO Christophe Weber to retire from Takeda in June 2026 after 12 yearsJulie Kim, president of the U.S. Business Unit, named to succeed Weber after multi-year succession …

1 天前 · Takeda Pharmaceutical said on Thursday its CEO Christophe Weber will retire after more than a decade at the helm of Japan's biggest drugmaker as the company upped its full-year …

2 天之前 · Takeda Pharmaceutical Co.’s board has selected Julie Kim, the head of the company’s US unit, to replace Christophe Weber as the drugmaker’s new chief executive officer. Kim, …

2 天之前 · Takeda (TOKYO:4502/NYSE:TAK) has announced that Julie Kim, current president of Takeda's U.S. Business Unit, will succeed Christophe Weber as CEO when he retires in June …